Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
Clinical trial NCT06101329 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06101329
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-17
- Primary completion
- 2026-07-22
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.